OUR RESEARCH FOCUS
Our research group investigates the molecular mechanisms governing the fate of hematopoietic stem and progenitor cells in health and disease.
Healthy HSPCs generate the full spectrum of blood and immune cells through tightly regulated self-renewal and differentiation capacities.
Perturbations of these properties can lead to blood cancers, such as leukemia.
Recent News
























Key milestones
January 2023
TREMBLAY LAB joins the Children’s Hospital Research Institute of Manitoba (CHRIM) - the first research facility dedicated exclusively to pediatric research in the prairie provinces.
September 2022
TREMBLAY LAB joins the Paul Albrechtsen Research Institute @ CancerCare Manitoba and the Department of Immunology, University of Manitoba.
Launch of the translational leukemia research program
April 2026
Comprehensive revamp of the TREMBLAY LAB website!
Launch of the fundamental hematopoiesis research program
October 2022
Rollout of the TREMBLAY LAB website!


